| Attributes | Values |
|---|
| rdf:type
| |
| description
| - videnskabelig artikel (da)
- article científic (ca)
- articolo scientifico (it)
- artigo científico (pt)
- bilimsel makale (tr)
- vedecký článok (sk)
- vetenskaplig artikel (sv)
- vědecký článek (cs)
- wetenschappelijk artikel (nl)
- wissenschaftlicher Artikel (de)
- научни чланак (sr)
- article scientifique (fr)
- artículu científicu espublizáu en 2005 (ast)
- наукова стаття, опублікована в жовтні 2005 (uk)
- scientific article published on 31 October 2005 (en)
- مقالة علمية نشرت في 31 أكتوبر 2005 (ar)
|
| publication date
| |
| publication date
| |
| cites work
| |
| cites work
| - Serum tumor markers in the management of ovarian, endometrial and cervical cancer
- Can initial serum cyfra 21-1, SCC antigen, and TPA levels in squamous cell cervical cancer predict lymph node metastases or prognosis?
- Radioimmunoassay for tumor antigen of human cervical squamous cell carcinoma
- Application of tumor markers CEA, TPA, and SCC-Ag in patients with low-risk FIGO stage IB and IIA squamous cell carcinoma of the uterine cervix
- Pretreatment serum squamous cell carcinoma antigen: a newly identified prognostic factor in early-stage cervical carcinoma
- Cytokeratins of normal epithelia and some neoplasms of the female genital tract
- Clinical value of pretreatment serum Cyfra 21-1, tissue polypeptide antigen, and squamous cell carcinoma antigen levels in patients with cervical cancer
- Cytokeratin 19 fragments: a new marker for non-small-cell lung cancer
- Cyfra 21-1 in monitoring cervical cancer: a comparison with tissue polypeptide antigen and squamous cell carcinoma antigen
- Preoperative serum SCC, CA125, and CA19-9 levels and lymph node status in squamous cell carcinoma of the uterine cervix
- SCC antigen in the serum as an independent prognostic factor in operable squamous cell carcinoma of the cervix.
- Monitoring the course of cervical carcinoma with the squamous cell carcinoma serum radioimmunoassay
- Cytokeratin subunit 19 measured by CYFRA 21-1 assay in follow-up of cervical cancer
- Cancer of the uterine cervix: sensitivity and specificity of serum Cyfra 21.1 determinations
- Cancer of the uterine cervix: sensitivity and specificity of serum squamous cell carcinoma antigen determinations
- Serum levels of cytokeratin 19 fragments in cervical cancer
- Tumor markers in gynecologic oncology
- Prognostic significance of serum fragments of cytokeratin 19 measured by Cyfra 21-1 in cervical cancer
- Study of a new tumor marker, CYFRA 21-1, in squamous cell carcinoma of the cervix, and comparison with squamous cell carcinoma antigen
- Value of Cyfra 21-1, TPA, and SCC-Ag in predicting extracervical disease and prognosis in cervical cancer
|
| author name string
| |
| author name string
| - Hee-Sug Ryu
- Suk-Joon Chang
- Jung-Pil Lee
- Young-Ji Byun
|
| rdfs:label
| - Relationship between pre-treatment serum SCC (squamous cell carcinoma) antigen, Cyfra 21-1 levels, and survival in squamous cell carcinoma of the uterine cervix (en)
- Relationship between pre-treatment serum SCC (squamous cell carcinoma) antigen, Cyfra 21-1 levels, and survival in squamous cell carcinoma of the uterine cervix (nl)
- Relationship between pre-treatment serum SCC (squamous cell carcinoma) antigen, Cyfra 21-1 levels, and survival in squamous cell carcinoma of the uterine cervix (ast)
|
| skos:prefLabel
| - Relationship between pre-treatment serum SCC (squamous cell carcinoma) antigen, Cyfra 21-1 levels, and survival in squamous cell carcinoma of the uterine cervix (en)
- Relationship between pre-treatment serum SCC (squamous cell carcinoma) antigen, Cyfra 21-1 levels, and survival in squamous cell carcinoma of the uterine cervix (nl)
- Relationship between pre-treatment serum SCC (squamous cell carcinoma) antigen, Cyfra 21-1 levels, and survival in squamous cell carcinoma of the uterine cervix (ast)
|
| name
| - Relationship between pre-treatment serum SCC (squamous cell carcinoma) antigen, Cyfra 21-1 levels, and survival in squamous cell carcinoma of the uterine cervix (en)
- Relationship between pre-treatment serum SCC (squamous cell carcinoma) antigen, Cyfra 21-1 levels, and survival in squamous cell carcinoma of the uterine cervix (nl)
- Relationship between pre-treatment serum SCC (squamous cell carcinoma) antigen, Cyfra 21-1 levels, and survival in squamous cell carcinoma of the uterine cervix (ast)
|
| author
| |
| author
| |
| title
| |
| title
| - Relationship between pre-treatment serum SCC (squamous cell carcinoma) antigen, Cyfra 21-1 levels, and survival in squamous cell carcinoma of the uterine cervix (en)
|
| page(s)
| |
| page(s)
| |
| instance of
| |
| instance of
| |
| main subject
| |
| main subject
| |
| PubMed ID
| |
| PubMed ID
| |
| PubMed ID
| |
| published in
| |
| published in
| |
| issue
| |
| volume
| |
| issue
| |
| volume
| |
| DOI
| |
| DOI
| |
| DOI
| - 10.4143/CRT.2005.37.5.302
|
| copyright license
| |
| copyright status
| |
![[RDF Data]](/fct/images/sw-rdf-blue.png)
![[cxml]](/fct/images/cxml_doc.png)
![[csv]](/fct/images/csv_doc.png)
![[text]](/fct/images/ntriples_doc.png)
![[turtle]](/fct/images/n3turtle_doc.png)
![[ld+json]](/fct/images/jsonld_doc.png)
![[rdf+json]](/fct/images/json_doc.png)
![[rdf+xml]](/fct/images/xml_doc.png)
![[atom+xml]](/fct/images/atom_doc.png)
![[html]](/fct/images/html_doc.png)